JUL 2014 ARTICLE LIST >>
PharmaTutor (July- 2014)
ISSN: 2347 - 7881
Received On: 16/04/2014; Accepted On: 19/05/2014; Published On: 01/07/2014
AUTHORS: Ranjana Joshi*, Shikha Jain, Kirti Jatwa, Monika Thakur, Anies Shaikh
Department of Pharmaceutics,
Mahakal Institute of Pharmaceutical Studies,
Ujjain, Madhya Pradesh, India
ranjanajoshipharma@gmail.com
ABSTRACT:
Prolotherapy is a technique which can be used to treat pain and injuries. Osteoarthritis is a disease acquired from daily wear and tear of joints and also due to injury. Prolotherapy is an injection technique which causes inflammation at the site of injection, new blood vessels form and mature, pain subsides and collagen density and tissue strength are increased. It works by stimulating the body’s own healing mechanism at the site of injection leading to long lasting relief of the injured area. This review focuses on the treatment of osteoarthritis using prolotherapy.
How to cite this article: R Joshi, S Jain, K Jatwa, M Thakur, A Shaikh; Prolotherapy for Arthritis- A Review; PharmaTutor; 2014; 2(7); 54-62
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1.VanItallie T.B."Gout: epitome of painful arthritis". Metab. Clin. 2010;Exp. 59 : S32–6.
2.Torland Paul D, Kozar Albert J, Zannotti Chad M, Ewing Shannon E. Regenerative injection Therapy, Valley sports physicians and orthopedic medicine, Valley Sports Physicians 54 West Avon Road,Suite 202
3.Alderman Donna. Prolotherapy for Knee pain. Practical pain management. 2007;70-79
4.Goswami Amitabh. Patient education and self-Advocacy: Questions and responses on pain management. Journal of Pain & Palliative Care Pharmacotherapy. 2012;26:376–378.
5.Baumgartner Joel. Prolotherapy and PRP(Platelet Rich Plasma). Rejuvmedical orthopedic & sports medicine; (320), 217-8480.
6.Banks Allen R. A rational for prolotherapy. Journal of Orthopaedic Medicine .1991;13:3.
7.Judson C.H, Wolf J.M., Lateral Epicondylitis: A Review of Injection Therapies. The Orthopedic Clinics of North America. 2013;4:615-623.
8.Distal LM, Best TM. Prolotherapy: a clinical review of its role in treating chronic musculoskeletal pain. PM&R. 2011;3:S78–S81.
9.Reeves KD. Prolotherapy: Basic Science, Clinical Studies, and Technique. In Lennard TA (Ed) Pain Procedures in Clinical Practice. Hanley and Belfus. Philadelphia. 2000: 172-190.
10. Laura Johannes. A Pinch of Sugar for pain. Wall Street Journal.2012
11.Dagenais S. Intraligamentous injection of sclerosing solutions: prolotherapy for spine pain: a critical review of the literature. Spine J. 2005;5:310–328.
12.Reeves Dean K. Prolotherapy: basic science, clinical studies and technique. 172-190. Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med. 2006;354(8):841-848.
13.Felson DT. Epidemiology of osteoarthritis. In: Brandt KD DM, Lohmander LS, eds. Osteoarthritis. Oxford, England: Oxford University Press; 2003:9-16.
14.Rabago D, Slattengren A, Zgierska A. Prolotherapy in primary care practice. Prim Care. 2010;37:65-80.
15.Reeves KD, Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med. 2000;6(2):68-74,77-80.
16.Fleming S, Rabago DP, Mundt MP, Fleming MF. CAM therapies among primary care patients using opioid therapy for chronic pain. BMC Complement Altern Med. 2007;7:15.
17.Rabago D, Best T M, Zgierska A E, Zeisig E, Ryan M, Crane D. A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. Br J Sports Med 2009;43:471–481.
18.Gombotz H, Gries M, Sipurzynski S, Fruhwald S, Rehak P. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. Acta Anaesthesiol Scand. 2000 ;44:737-747.
19.Matsuda S, Kondo M, Mashima T, Hoshino S, Shinohara N, Sumida S. Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty. Orthopedics. 2001; 24:41-44
20.Bishop MR, Tarantolo SR, Geller RB, et al. A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. 2000;96:80-85.
21.Garcia Carbonero R, Mayordomo JI, Tornamira MV. Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial. J Natl Cancer Inst. 2001;93:31-38.
22.Reeves K. Dean, Hassanein Khatab M., Long Term Effects Of Dextrose Prolotherapy For Anterior Cruciate Ligament Laxity. Alternative Therapies, 2003; 9: 58-62.
.png)
